Xinan Sheng2 articles listing Xinan Sheng in Nature Communications, indexed by Paperzzz from Crossref and OSF.A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma Nature CommunicationsComprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets Nature Communications